TYMS and acute lymphoblastic leukemia: Using a candidate gene approach, we have shown previously that germline copy number polymorphisms (in GSTM1, TYMS, and UGT1A1) were significantly associated with leukemia cell gene expression in patients with acute lymphoblastic leukemia, with the former two polymorphisms also being associated with risk of ALL relapse[29], [30].